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Abstract
Background: The hospital-adapted A1 group of Enterococcus faecium remains an organism of significant concern in
the context of drug-resistant hospital-associated infections. How this pathogen evolves and disseminates remains
poorly understood.
Methods: A large, globally representative collection of short-read genomic data from the hospital-associated A1
group of Enterococcus faecium was assembled (n = 973). We analysed, using a novel analysis approach, global
diversity in terms of both the dynamics of the accessory genome and homologous recombination among
conserved genes.
Results: Two main modes of genomic evolution continue to shape E. faecium: the acquisition and loss of genes,
including antimicrobial resistance genes, through mobile genetic elements including plasmids, and homologous
recombination of the core genome. These events lead to new clones emerging at the local level, followed by the
erosion of signals of clonality through recombination, and in some identifiable cases producing new clonal clusters.
These patterns lead to new, emerging lineages which are able to spread globally over relatively short timeframes.
Conclusions: The ability of A1 E. faecium to continually present new combinations of genes for potential selection
suggests that controlling this pathogen will remain challenging but establishing a framework for understanding
genomic evolution is likely to aid in tracking the threats posed by newly emerging lineages.
Background
Enterococcus faecium, a commensal of the gastrointes-
tinal tract, is a common cause of serious hospital-
associated infections [1]. Therapy is complicated by re-
sistance to multiple antibiotics, including vancomycin; as
a consequence, the World Health Organization includes
vancomycin-resistant E. faecium (VRE) on its list of pri-
ority multidrug-resistant pathogens. E. faecium tends to
persist in the hospital environment, leading to outbreaks
without clear transmission chains and the dissemination
of antimicrobial resistance from a variety of sources [2],
making the control of hospital E. faecium challenging.
Vancomycin resistance occurs in 30–50% of isolates in
some countries and is considered the greatest threat to
successful treatment. Vancomycin resistance is almost
always linked to the presence of the vanA and/or vanB
gene cluster, whose relative frequencies vary in space
and time [3, 4]. Optimal therapy for VRE infections re-
mains uncertain; daptomycin and linezolid are the most
commonly utilised last-line antibiotics. Besides plasmid-
mediated linezolid resistance leading to sporadic out-
breaks, resistance to last-line antibiotics remains
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: Sebastiaan.vanhal@health.nsw.gov.au
1Department of Infectious Disesase and Microbiology, Royal Prince Alfred
Hospital, Sydney, NSW, Australia
2University of Sydney, Sydney, NSW, Australia
Full list of author information is available at the end of the article
van Hal et al. Genome Medicine           (2021) 13:52 
https://doi.org/10.1186/s13073-021-00868-0
uncommon [5]. Mutations in any of three genes (liaF,
liaS, liaR) linked to cell wall stress responses, or in genes
for cardiolipin synthase (cls) or glycerophosphoryl dies-
ter phosphodiesterase (gdpD), may confer daptomycin
resistance, while mutations in 23S rRNA, the Cfr rRNA
methyltransferase gene or optrA may lead to linezolid re-
sistance [6, 7]. It remains unclear whether these resist-
ance mutations arise preferentially on particular gene
sequences or are associated with specific circulating
clones.
Isolates of E. faecium can be placed in two genomically
distinguishable groups, also referred to in the literature
as “lineages” or “clades”: a hospital-associated lineage
(clade A) and a community-associated lineage (clade B)
[8]. Clade A is further split into clade A1, represented by
human clinical isolates, and several non-A1 sub-clades
[9] that, together with clade B isolates, are rarely found
in hospitalised patients [10]. Previous genomic studies of
A1 E. faecium have revealed substantial levels of genome
plasticity and evidence of clonal outbreaks in individual
hospitals [2]. At the scale of national or regional surveil-
lance, patterns of A1 evolution become more complex;
for example, new clone(s) have been reported that have
outcompeted and ultimately replaced existing clones
(e.g. vanA ST1421 in Australia or vanB ST192 in
Germany) [3, 4]. How local institutional and regional
factors, including infection control and antimicrobial
stewardship, shape the global population structure of
hospital E. faecium, and specifically clade A1, remains
uncertain.
Standard genomic analyses of bacterial evolution em-
ploy phylogenetic modelling of mutations occurring in
the core genome, identified either by mapping to a refer-
ence or identifying SNPs in core genes in de novo as-
semblies. Both approaches disregard much of the
information that impacts inferences of genomic relation-
ships. In addition, when substantial ongoing recombin-
ation is the main driver of genomic diversity,
phylogenetic methods fail to accurately capture co-
ancestry relationships, i.e., they fail to link genomes that
share the most recent ancestors for the largest propor-
tion of their genome (and may instead group together
genomes which have independently acquired a similar
recombinant sequence) [11, 12]. Accordingly, we
adopted a combined analysis approach to examine the
population structure and evolutionary dynamics of this
important hospital pathogen by using similarity in gene
content and proximity in co-ancestry to recover genomic
relationships. Our approach attempts to maximise the
utilisation of genomic information for a large, globally
representative collection of A1 E. faecium isolate se-
quences. It defines genomic relationships based on the
presence or absence of genes within the pan-genome,
with subsequent fine-tuning based on admixture
patterns of core-genome SNPs. These data have allowed
us to investigate the size and structure of the Group A1
pan-genome, the population structure that has formed
during its worldwide dissemination, and signatures of re-
peated acquisition of antimicrobial resistance, providing
a new description of the mechanisms involved in the on-
going evolution of a globally significant pathogen.
Methods
Defining A1 group isolates
Short-read sequence data from a total of 1100 E. faecium
isolates were contributed by study investigators. Of
these, 321 were newly sequenced and uploaded to NCBI
under project number PRJNA63689 [13], with the
remaining sequences (n = 774) downloaded from NCBI.
Five isolates failed quality checks (using fastQC v0.11.9)
after adapter trimming using trimmomatic v0.38 [14]
and were excluded. To enable previous grouping, the
dataset was supplemented with 52 [clade A1 (n = 14),
clade A2 (n = 28) and clade B (n = 10)] additional se-
quences from Lebreton et al. [8]. Reads were mapped to
Aus0004 (a closed annotated Australian genome, Gen-
Bank: CP003351) using bwa [15]. Single nucleotide poly-
morphisms (SNPs) were identified in each isolate using
FreeBayes [16] with alleles filtered for read depth (> 20),
and mapping quality, requiring 90% of reads to support
a variant allele call. The final SNP matrix included only
variant sites present in > 75% of isolates. Using hierBAPS
[17] with 2 levels of hierarchy and maxK of 20, isolates
were assigned to A1 (n = 997), A2 (n = 109) and B (n =
41) groups [8]. Isolate details and associated metadata
can be found in Additional file 1: Table S1.
Pan-genome analysis and clustering of A1 hospital-
associated isolates
Non-enterococcal reads, based on taxonomic k-mer
matches using kraken2 [18], were discarded to prevent
subsequent spurious gene calls as a result of contamin-
ation. Sequences were assembled using SPAdes v3.13.1
[19] under the “careful” option, with assemblies failing
quality metrics excluded (n = 24). Contigs < 2000 bp
were removed and discarded from individual assemblies,
which were annotated using prokka v1.13 [20] prior to
pan-genome discovery using panaroo v1.1.2 [21] under
the “sensitive” mode. This setting is optimised to find all
genes present in all isolates with homologous genes clas-
sified when gene sequences differ by > 5% between iso-
lates. The identified panaroo core-genome was larger
than previous estimates and therefore the analysis was
duplicated using Roary [22].
The panaroo output, a gene presence-absence matrix,
was used to cluster isolates after initial dimension reduc-
tion using Barnes-Hut t-Distributed Stochastic Neigh-
bour Embedding in R with the Rtsne v0.15 package
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https://github.com/jkrijthe/Rtsne [23]. The optimal
number of clusters was evaluated with aid of the fviz_
nbclust function within the R factoextra v1.0.6 package
https://github.com/kassambara/factoextra [24].
Subsequently, cluster membership was refined using
the ChromoPainter tool embedded in FineSTRUCTURE
v2.1.3 [25] with a starting mean recombination rate of
2.3 × 10−7. This method models each genome as a suc-
cession of haplotype fragments from other genomes in
the collection and assigns the closest matching sequence
as the donor haplotype with switches between donors
occurring at ancestral recombination breakpoints. All
these genome sections can then be ascribed or “painted”
according to their inferred origins among groups of re-
lated donor sequences. Isolates with similar admixture
patterns across the majority of their genome, represent-
ing a continuous line of ancestry, signify specific line-
ages. These lineages coalesce to form clusters with
isolates expected to share the greatest proportion (al-
ways > 35%) of their co-ancestry with another isolate
assigned to the same cluster. Conversely, highly admixed
isolates, as a result of numerous recombination events,
could not be assigned to any pan-genome assigned clus-
ter and were excluded from further analysis. For
admixed regions, the likely “donor” isolate (and by infer-
ence the country of origin) can be found by looking for
the isolate that contains the most similar sequence in
the alternative clusters.
Final refined clustering of A1 isolates can be found in
Additional file 1: Table S1.
Phylogenetic and spatial analysis
Maximum clade credibility trees were constructed on
cluster-specific SNP matrices, excluding isolates with
unknown collection dates, following masking of identi-
fied recombination sites using ClonalFrameML [26]. For
each relevant cluster, several population models (con-
stant, exponential and skyline) in combination with vari-
ous clock models (strict, relaxed exponential and
random) were run for 3 × 108 iterations using BEAST
v2.6.1 [27]. Resulting trees were pruned, and a maximum
clade credibility tree was obtained from the optimally
performing model.
A spatial analysis was performed for Cluster 2, with in-
clusion of a geographical trait based on latitude and lon-
gitude co-ordinates and phylogenetic nodes assigned to
a geographical location based on ancestral state recon-
struction. Transmission links for isolates and nodes were
inferred using genomic, spatial and temporal variables
and visualised using SpreaD3 [28] under a discrete trait
model. All isolates and nodes are represented by a net-
work of connecting lines depicting the likely “origin”
and “destination”. Lines are coloured according to “des-
tination” location.
MLST, resistome, virulome and plasmidome analysis
Multi-locus sequence typing was performed using the de
novo assemblies. Isolate resistomes were predicted using
AMRfinder specifying E. faecium [29]. Mutation-based
resistance for daptomycin was predicted by annotation
of variants against the Aus0004 genome. A median-
joining network of the liaFSR genes was constructed
using NETWORK v10.0 [30]. 23S rRNA-based linezolid
resistance was predicted as previously described [31].
The virulome was predicted using blastn against the
downloaded virulence factor database [32]. To determine
genes likely associated with plasmids, we implemented
mlplasmids [33] using de novo assemblies with a poster-
ior probability cut-off of 0.7.
Statistical analysis
Statistical analyses for associations were performed using
the appropriate two-sided statistical test following con-
sideration of the data distribution. A p value < 0.05 was
considered significant, with all calculations performed
using the R stats package v 3.4.4 [34].
Results
Defining group A1 isolates in a global collection of
hospital E. faecium
Groups that had previously published E. faecium gen-
ome data were invited to contribute. Participants were
requested to provide short-read sequence data repre-
senting randomly selected isolates, spread across time,
from collections of vancomycin-susceptible and
vancomycin-resistant E. faecium originating from hospi-
talised patients in any country, ensuring that isolates
from the same hospital were not enriched for known
outbreaks, based on local epidemiological data.
Sequence variation identified through mapping reads
to a reference genome was used to cluster isolates with
hierBAPS [17], recovering the previously published A1
(n = 997), A2 (n = 109) and B (n = 41) groups. Of the A1
isolates, 24 subsequently failed de novo assembly quality
filters and were excluded, leaving 973 A1 isolates origin-
ating from 31 countries, spanning a 30-year period
(1986–2016) for analysis in this study.
Heterogeneity among group A1 hospital E. faecium
isolates
To study the relationships among E. faecium A1 isolates,
a pan-genome analysis based on de novo-assembled ge-
nomes, investigating large-scale variation comprising the
presence and absence of genes and distinct forms of
genes, was undertaken using Panaroo [21]. The 973 A1
isolates were separated into 10 clusters (Fig. 1a).
Recognising the role of homologous recombination as
a dominant, recurring force in the continuing genomic
evolution of E. faecium, the assignment of isolates to
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pan-genome clusters was refined using chromosome
painting [25]. This analysis traces the signal of co-
ancestry shared between isolates, based on reads mapped
to a reference core genome sequence of 1926 genes
(those present in > 95% of isolates), and provides a “fin-
gerprint” that distinguishes all but the most closely re-
lated isolates. Chromosome painting identified 78
isolates, typically visualised at the edges of the pan-
genome clusters (Fig. 1a, b), whose core genomes re-
vealed substantial ancestry in multiple clusters. For the
remaining 895 isolates, aggregating fragments of se-
quence including those transferred between lineages, a
mean of 81% (IQR 75–89%) of an isolate’s core genome
shared co-ancestry with other isolates within the cluster.
Fig. 1 Clustering among global A1 isolates. a Clustering of 973 E. faecium group A1 isolates based on the presence or absence of genes within
the pan-genome identified using Panaroo. Labelled clusters are represented on a reduced dimensionality 2-D grid with member isolates coloured
as shown in the legend. At a core-genome SNP level isolates within the same cluster are expected to share the same ancestry across the majority
of their genomes. Using ChromoPainter, substantial core-genome admixture was detected in the 78 grey-shaded isolates, resulting in their
exclusion from the designated pan-genome clusters. b The levels of admixture of the aforementioned 78 grey-shaded isolates in a (left) are
contrasted with estimated admixture of 78 randomly chosen isolates from the remaining 895 isolates. The x-axis label shows the initial cluster
assignment based on the pan-genome with the y-axis bars representing co-ancestry signals originating from other clusters, using the same
colours as in a
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Pan-genome and plasmidome
Panaroo identified 15,788 genes and gene variants
among A1 isolates, with a median genome size of 2781
identifiable genes. Along with 1926 genes present in >
95% of isolates, 2084 “shell” genes were found in 10–
95% of genomes, arranged in groups of similar frequency
hinting at assemblages of genes shared across multiple
clusters. These estimates were recapitulated using Roary
[22] and are larger than previously reported, indicating
the influence of non-human isolates in limiting core-
genome size estimates in other studies [10]. A substan-
tial proportion (854; 40.9%) of genes were identified on
plasmids (Additional file 2: Figure S1), providing evi-
dence of plasmid gain contributing to cluster emergence
and diversification with 129 of the 366 cluster-associated
genes occurring on a plasmid in at least one isolate
(Fig. 2). The total frequencies of plasmid-derived genes
were similar across clusters. Most of the remaining 11,
778 genes (76% of the total) were found in no more than
a handful of closely related isolates (< 5% of isolates),
reflecting in each case a probable single acquisition from
an outside source. Although the average nucleotide di-
versity for core genes was low (pi = 0.0056); substantial
variability, through the identification of homologues with
> 5% divergence, in some ubiquitous genes including
housekeeping genes (adk, atpA and pstS) was noted.
These patterns likely indicate a single clonal expansion
leading to A1 with infrequent replacement of function-
ally constrained genes from outside the E. faecium
species.
Patterns of A1 dissemination and admixture
Genome-wide nucleotide diversity among A1 E. faecium
isolates is small, stemming from its origin as a hospital-
restricted clone. Nevertheless, it is possible to detect
core genome lineages that have arisen by a combination
of mutation and admixture with non-A1 E. faecium. Of
the 10 clusters, some (9, 10) were found almost entirely
in one geographic location (country), while others were
limited to geographical regions (clusters 3 and 4 in Asia
and clusters 5 and 7 in Europe). Samples in the
remaining clusters (1, 2, 6, 8) originated from highly
overlapping, indistinct territories within Europe or inter-
nationally (Additional file 2: Figure S2). The genome se-
quences assigned to each of the generalised European/
world clusters typically include many of the oldest sam-
ples (especially cluster 2) in contrast with geographically
specific clusters (Additional file 2: Figure S3). The rela-
tionship between time-depth of sampling and diversity
suggests that A1 has evolved and disseminated over
timescales comparable with sampling times, i.e. decades.
We next focus on three selected clusters to examine
and illustrate distinct patterns of adaptation, admixture
between clusters and networks of spread. Cluster 5
Fig. 2 Cluster-associated genes. All 366 genes significantly associated (p < 0.05) with pan-genome clusters are depicted with chromosomal and
plasmid-derived genes coloured blue and red respectively. Of the 366 cluster-associated genes, 129 genes occurred on a plasmid in at least one
isolate. Genes (along the x-axis) are grouped by cluster (along the y-axis) as depicted in the legend. No gene was exclusively limited to any one
cluster, with the largest complement of genes associated with cluster 5 (n = 107)
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emerged in Denmark before disseminating across North-
ern Europe (Fig. 3). The single Australian isolate within
cluster 5 is suggestive of wider spread; however, the
identified expansion seems predominantly restricted to
mainland Europe. Substantial recombination (involving
all core genes) has resulted in highly variable patterns of
admixture at the gene level. However, isolates from a
single country retain a strong recent clonal signature in-
clusive of the pan-genome (depicted in panels A and B
in Fig. 3), superimposed on a deeper structure of emer-
gence, adaptation and expansion prior to spread. The
scatter of Dutch isolates, for example, across the cluster
phylogeny, reveals a pattern of homogenisation across
Europe, leading to a picture of the co-circulation of mul-
tiple subclones that could not previously be appreciated;
these co-circulating lineages augment the pool of core-
genome variants and accessory genes that can contribute
to the emergence of new lineages (Fig. 3).
To appreciate the granularity of the patterns of admix-
ture and genetic exchange between clusters and isolates,
focus is switched to cluster 9, consisting exclusively of
isolates from Australia. The collection of cluster 9 iso-
lates in multiple institutions in several cities rules out a
single outbreak or clonal expansion event as a simple ex-
planation for this cluster (data not shown). Signals of re-
combination are observed across all genes, incorporating
sequences characteristic of all other clusters, in spite of
the low frequencies of some clusters in Australia. In fact,
local isolates provided the best match for a large propor-
tion (53%) of copying events from other clusters (Fig. 4),
confirming the duality of local acquisition of sequences
and links to the worldwide store of core genome vari-
ation. Sampling dates for cluster 9 were closely spaced,
obscuring the relationship between time and diversifica-
tion while remaining consistent with a rapid emergence.
Cluster 2, present in all sampled continents, was
chosen to examine the characteristics and routes of glo-
bal dissemination (Fig. 5). A phylogenetic analysis after
masking recombination revealed a similar substructure
as in cluster 5, in which clonal patterns are limited by lo-
cation and blurred by admixture patterns (Additional file
2: Figure S3). Given the considerable spread and time
depth of European isolates, the phylogeny is most con-
sistent with introduction(s) of E. faecium into the USA
from Europe, most probably from the UK. The lack of a
consistent pattern of vancomycin resistance genes
among most closely linked isolates in different countries
suggests the acquisition of vancomycin resistance at a
local level (Fig. 6) [9]. Cluster 2’s epicentre remains in
Europe, with regional links between Japan and Australia,
and North and South America.
Antimicrobial resistance and virulome
The availability of a globally representative collection of
E. faecium A1 isolates facilitated a survey of genes asso-
ciated with antimicrobial resistance (AMR). A
Fig. 3 Cluster 5: Evidence of local adaptation and regional dissemination. Maximum clade credibility tree of 129 cluster 5 isolates following
masking of recombination. The first column to the right of the tree is coloured by sampled country (key left upper corner: AUS, Australia; BEL,
Belgium; DEU, Germany; DNK, Denmark; ESP, Spain; EU, European Union; NLD, Netherlands). The subsequent column or heatmap depicts
admixture events across the core genes of isolates coloured by “donating” cluster (key below heatmap). Similar background patterns of admixture
are observed, accompanied by evidence of ongoing recombination at regional levels. Two such instances linked to Denmark and Germany are
highlighted by boxes A and B respectively. Time scale is shown on the y-axis below the phylogeny
van Hal et al. Genome Medicine           (2021) 13:52 Page 6 of 12
Fig. 4 Cluster 9. The bottom panel along the x-axis represents individual cluster 9 isolates (originating exclusively from Australia) with coloured
vertical bars showing individual admixture signals across their core-genome by donor cluster. The dashed line depicts an admixture threshold of
10%. The top half of the panel reflects the proportions of admixed regions by donor country (left) and donor cluster (right). Overall, cluster 9
isolates share the majority of their genome co-ancestry (between 61% and 98%) with other cluster 9 isolates. In admixed regions, the best
genomic match to the donor cluster originated from another Australian isolate in 53% of cases
Fig. 5 Dissemination routes of E. faecium across the world. Worldwide dissemination of genomes belonging to cluster 2 (n = 122) analysed using
spatial, temporal and genomic data through BEAST v2.6 and visualised using SpreaD3. Coloured nodes on the map represent an isolate’s country
of origin (as shown in the legend), while connecting lines are coloured by destination location. An expanded view is shown in panel a to show
inferred spread of E. faecium isolates across Europe with complex links between and within countries. b E. faecium dissemination across the globe
with surrounding circle sizes proportional to the number of lineages (isolates that share the same continuous line of ancestry) that occur in that
location and captures the absolute and relative intensity of the local spread at any given point in time
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vancomycin resistance gene cluster was present in 544
(56%; 261 vanA, 283 vanB) A1 isolates. This study reca-
pitulated known associations between country and mode
of vancomycin resistance. Cluster 9 (predominantly Aus-
tralian) and cluster 7 (predominantly German) were
skewed towards vanB, while cluster 6 (European coun-
tries) was significantly more likely to harbour vanA (p <
0.05) (Fig. 6a). The cluster 9 correlation is driven by the
dominance of a single multi-locus sequence type, ST796
in that cluster (Additional file 1: Table S1), whereas in
clusters 6 and 7 multiple acquisitions of vancomycin re-
sistance are implicated. Thus, the association of van type
with geography may be in part driven by the short-term
success of particular lineages of E. faecium.
Fig. 6 Antimicrobial Resistance. a Presence (red) or absence (white) of resistance genes grouped by isolates within Panaroo clusters along the y-
axis. Genes are named along the x-axis with mutational resistance represented by gene names highlighted by 2 asterisks and grouped by AMR
class. AG, aminoglycosides; LZ, linezolid; FI, folate inhibitors; FQ, fluoroquinolones; MLS, macrolide-lincosamide-streptogramin; DAP, daptomycin;
TET, tetracycline; VAN, vancomycin; and CAT, chloramphenicol. b Heatmap of the average number of antimicrobial resistance genes resulting in
resistance within isolates by country. No isolates were included from grey shades countries. c Circular dendrogram of the tetM gene with
designated cluster by colour depicted in the outer ring. Evidence of clustering is still seen (e.g. clusters 7, 8 and 9) but extensive transfer of alleles
between clusters by horizontal gene transfer is evident
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Trimethoprim resistance, encoded by the dfrG gene, was
similarly clonally associated (data not shown). Less
clonal and more dynamic patterns were observed for
tetM (tetracycline resistance) and aminoglycoside resist-
ance genes, with evidence for loss events and acquisition
of multiple distinct gene variants within a cluster.
Several non-synonymous variants in the liaSFR gene
cluster, including the daptomycin resistance mutations,
LiaR T73C and LiaST120A (CARD database) [35], were ob-
served in our collection. Resistance mutations were car-
ried together and emerged from only one of the two
common allele backgrounds (Additional file 2: Figure
S4), which were positively associated with clusters 1, 3
and 6 (p < 0.05). This background was detected in iso-
lates from most sampled countries studied, implying the
emergence of daptomycin resistance in most locations,
subject to local selection pressure. Although daptomycin
is generally used when treating a VRE infection, dapto-
mycin resistance was not associated with vancomycin re-
sistance in our sample set.
The G2576T mutation in 23S rRNA associated with li-
nezolid resistance was detected in 7 isolates, but, unlike
daptomycin, no association with clusters could be de-
tected. Plasmid-mediated linezolid resistance was found
in two isolates harbouring the optrA gene in conjunction
with fexA (florfenicol-chloramphenicol transporter gene)
and in 6 isolates containing the cfr(B) gene.
A1 E. faecium isolates carry a median 10 (range 5–15)
resistance genes for which country- and region-specific
(notably European) frequencies are observed (Fig. 6b).
Overall, E. faecium tends to be multi-resistant, harbour-
ing quinolone mutations (in both parC and gyrA genes)
and at least one gene conferring resistance to aminogly-
coside, macrolide-lincosamide-streptogramin, tetracyc-
line and antifolate antimicrobials. Over the study period,
hospital-associated A1 E. faecium has become more re-
sistant, from a median complement of 4 genes in 1986
to 11 in 2016 (Additional file 2: Figure S5). At the gene
level, there is evidence of extensive horizontal gene
transfer, in the form of multiple clonal backgrounds
within and shared between pan-genome clusters. One
such example, the tetM gene, depicted in Fig. 6c, illus-
trates a continuum from minimal admixture and on-
going cluster specificity (clusters 7, 8 and 9) to frequent
exchanges resulting in loss of cluster signals.
Ten putative virulence genes were detected in the A1
E. faecium isolates. Of these, 6 were found in > 75% of
isolates and included genes associated with biofilm for-
mation (bopD), adhesion (sgrA), bile salt hydrolase (bsh),
collagen binding (acm, clpP) and metal transporter
(psaA) genes (Additional file 2: Figure S6). The capsular
polysaccharide gene (cpsF) was present in less than 1%
of isolates and is generally not associated with virulence
in E. faecium. Differences in virulomes by cluster were
typically characterised by the reduced proportion of iso-
lates carrying specific virulence genes. The functional
consequences of these differences are unknown. Simi-
larly, whether these observations represent gene loss or
gain events is unknown as no specific patterns were ob-
served in relation to time, geography or country of
origin.
Discussion
The A1 clade of E. faecium has a worldwide distribution
in which it dominates the hospital population of disease-
causing E. faecium in each location where it has been
studied. The low levels of nucleotide diversity among
genes common to all isolates are consistent with the
emergence of A1 from the expansion of a single clone,
with substantial continuing evolution, during the past
several decades. The two main modes of genomic evolu-
tion that continue to shape E. faecium A1’s diversity and
population structure are the acquisition and loss of as-
semblages of genes that form the mobilizable genome
(through the acquisition of mobile genetic elements in-
cluding plasmids), and homologous recombination of
the core genome, in which clones that have emerged
since A1’s formation are recombined, eroding initial sig-
nals of clonality and in some identifiable cases producing
new clonal clusters. Both modes occur at large scales
and with considerable tempo, complicating large-scale,
genome-wide analyses of population history and
structure.
In this study of the largest available collection of di-
verse and globally distributed E. faecium genome se-
quences from hospitalised patients, comprising 973 A1
isolates from 31 countries collected over 30 years, we de-
fine a substantial pan-genome. The core genome con-
tained nearly 2000 genes, accompanied by 854 common
accessory genes encoded on plasmids (the “shell gen-
ome”), plus a much larger number of sporadically cap-
tured genes found in no more than a few isolates.
Several gene patterns appear to have been acquired inde-
pendently more than once, leading to geographically
specific clusters and providing a strong indication of on-
going interactions among A1 Enterococci in the gastro-
intestinal tracts of patients, where many of the same
genes are recycled into different clusters. Sporadic acqui-
sitions indicate that hospital E. faecium also retains ac-
cess to a much larger pool of potential genes that have
failed to become established in successful clusters.
Within each pan-genome cluster, we were able to
identify one or more dominant lineages defined as com-
mon haplotypes on which are superimposed imported
sequences, acquired through homologous recombin-
ation, whose origins are in other clusters. These isolates
include ones whose core genomes place them mid-way
between established lineages (e.g. the grey-coloured
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isolates depicted in Fig. 1) and provide the potential
starting point for new clusters. These patterns reveal a
continuing process of formation of clones, over relatively
short periods (decades), comprising newly recombined
genomes, some of which are then locally or regionally
successful while continuing to recombine and gain and
lose genes.
A recent analysis of a globally representative sample
set estimated the emergence of the hospital-associated
A1 E. faecium at ~ 302 years ago [36], in marked con-
trast with estimates as recent as 74 years [8]. This dis-
crepancy is difficult to resolve using existing methods,
since accurate phylogenomic analyses rely on the as-
sumptions that recombination occurs across a restricted
part of the genome and that these regions can be reliably
detected and removed. Our analysis reveals recombin-
ation across the whole genome, even in relatively small
sample subsets. Consequently, molecular clock ap-
proaches are prone to inaccuracies, providing an explan-
ation for wide discrepancies in estimates. Leaving aside
phylogenetic analyses, the very low diversity of large
parts of the genome and the global distribution of A1
genomes is consistent with the emergence of E. faecium
A1 over recent decades, followed by global
dissemination.
In contrast with a lack of precise information about its
date of emergence, our analysis yields some observations
relevant to E. faecium A1’s origins. The A1 population
in Europe contains more distinct lineages (clusters) than
in other sampled locations, and this is reflected in the
evidently complex history of recombination in cluster 2.
In contrast, other well-sampled locations such as
Australia reveal a less complex, more geographically spe-
cific pattern of sequence exchange. These observations
are consistent with Europe as the birthplace of and lon-
gest established home of A1, a conclusion that needs to
be tested, given the limited number of American isolates
in our study and the potential resulting sampling bias.
Our improved understanding of the processes through
which A1 E. faecium continues to evolve may help us to
better understand the dynamics of selectable traits such
as antimicrobial resistance. Our analysis suggests that
gain and loss of van elements (either the vanA or the
vanB cassette) leading to vancomycin resistance is com-
mon enough that geographic specificities are an accident
of history, driven by chance through the acquisition and
spread of a particular cassette in a particular population.
Rather than reflecting a genetic propensity to carry a
particular van type, common van loss events are likely
to be followed by re-acquisition of the same van type
simply because it happens to be frequent in that particu-
lar population [2, 37]. This pattern (that gene acquisition
is most likely to reflect the distribution of circulating
genes) is mirrored by the accessory genome as a whole
and explains how a particular complement of shell genes
(a pan-genome cluster) exists without being completely
linked to a set of core genome lineages. The implication
of these observations is that the raw materials for pheno-
typic plasticity may be population-specific in the short
term, but subject to global dissemination and mixing
over longer timescales.
Our study also reveals the distinct dynamics under-
lying resistance to the last-line antibiotic, daptomycin.
The variants responsible for daptomycin resistance only
appear on one of two ancestral forms of the liaS gene
that are associated with clusters and geography but
nevertheless appear in all populations, implying that mu-
tational selection for resistance is only possible in some
infections, but the requisite genotypic background may
eventually spread by recombination combined with
selection.
Conclusions
The patterns of variation that we describe for A1, the
main hospital-adapted lineage of E. faecium, illustrate
the ease with which new phenotypes are likely to con-
tinue to emerge, driven by local variations in selection
and access to distinct gene pools via both homologous
recombination and an extensively mobilizable pan-
genome. These genomic features suggest that controlling
the hospital spread of E. faecium will remain
challenging.
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